claridhy phase iii trial of ivosidenib in cca
Published 4 years ago • 159 plays • Length 8:00Download video MP4
Download video MP3
Similar videos
-
1:29
claridhy: ivosidenib in cca
-
2:42
final results from claridhy: ivosidenib in idh1-mutated cca
-
1:37
comment: targeted therapy ivosidenib in cholagiocarcinoma
-
2:00
dr. abou-alfa on the results of the claridhy trial in advanced cholangiocarcinoma
-
6:53
ivosidenib for advanced idh1-mutated cca
-
4:10
explore idh mutations
-
5:15
il 22
-
2:43
investigational product in clinical trials
-
4:54
claridhy: targeted therapy ivosidenib for advanced cholagiocarcinoma
-
1:12
final results from claridhy
-
7:02
claridhy: ivosidenib vs placebo in advanced cholangiocarcinoma with idh1 mutatin
-
0:47
dr. winer discusses the fda approval of ivosidenib in aml
-
1:34
dose-escalation and expansion study of ivosidenib in patients with idh1-mutant mds
-
1:14
dr. mims on fda approval of ivosidenib in patients with aml
-
2:05
idh inhibitors for cholangiocarcinoma
-
12:47
ac21 - mitesh borad: updates on genomically formed therapy in cca - idh1/idh2
-
3:10
results of phase ii trial of olutasidenib in patients with r/r midh1 aml
-
25:39
single and dual agent oncology dose-escalation designs in east® 6.4 - pantelis vlachos
-
1:07:55
iddi webinar: design and analysis of phase ii trials in oncology
-
2:06
dr. choueiri on phase i/ii data of mk-6482 in advanced clear cell rcc
-
56:21
ccf webinar: new directions in treating idh1-mutant cholangiocarcinoma
-
1:01
impact of clinical trials: afshin dowlati, md